Macrogenics (MGNX) Equity Ratio (2012 - 2026)

Macrogenics (MGNX) has 15 years of Equity Ratio data on file, last reported at 0.1 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.1, down 72.38% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.1 (down 72.38% YoY), and the FY2025 annual result was 0.22, down 51.2% from the prior year.
• Equity Ratio retreated to 0.1 in Q1 2026 per MGNX's latest filing, from 0.22 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.66 in Q1 2022 and troughed at 0.1 in Q1 2026.
• A 5-year average of 0.42 and a median of 0.44 in 2024 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2024 and 2026: Equity Ratio jumped 34.41% in 2024, then plunged 72.38% in 2026.
• A 5-year view of Equity Ratio shows it stood at 0.51 in 2022, then grew by 1.0% to 0.51 in 2023, then slipped by 13.27% to 0.44 in 2024, then tumbled by 51.2% to 0.22 in 2025, then slumped by 55.05% to 0.1 in 2026.
• Business Quant data shows MGNX's Equity Ratio at 0.1 in Q1 2026, 0.22 in Q4 2025, and 0.25 in Q3 2025.